Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ: QDEL )

44.37 -0.48 (-1.06%)
Streaming Delayed Price Updated: 12:36 PM EST, Dec 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 238,525
Open 44.72
Bid (Size) 44.31 (3)
Ask (Size) 44.44 (1)
Prev. Close 44.84
Today's Range 44.09 - 45.30
52wk Range 29.73 - 75.86
Shares Outstanding 41,632,759
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
From QuidelOrtho Corporation
Via Business Wire
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
QuidelOrtho's secondary offering of 8.26 million shares is priced at $38.58, removing an investor overhang, according to William Blair's analysis. 
Via Benzinga

Performance

YTD
-40.63%
-40.63%
1 Month
+10.53%
+10.53%
3 Month
-0.84%
-0.84%
6 Month
+30.83%
+30.83%
1 Year
-41.10%
-41.10%

More News

Read More
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Via Benzinga
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
Top 4 Health Care Stocks That May Plunge This Quarter
Via Benzinga
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
QuidelOrtho Reports Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in Three Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces New R&D Executive Leader
From QuidelOrtho Corporation
Via Business Wire
A Biotech Breakout Will Be Led By Small Caps
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
From QuidelOrtho Corporation
Via Business Wire
Why QuidelOrtho Stock Blasted 10% Higher Today
Via The Motley Fool
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
Via Benzinga
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
QuidelOrtho Reports Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
QuidelOrtho to Report Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.